Clinuvel Pharmaceuticals (CLVLF)
$4.82-0.05 (-1.03%)
CLVLF
Clinuvel Pharmaceuticals earnings date
$4.82
At close:-0.05 (-1.03%)
Clinuvel Pharmaceuticals (CLVLF) Q2 2024 Earnings Report
42 Followers
CLVLF Q2 2024 EPS Results
- Actual EPS
- $0.15
- Consensus EPS
- $0.18
- Beat/Miss
- Missed by -$0.03
- One Year Ago EPS
- $0.15
CLVLF Q2 2024 Revenue Results
- Actual Revenue
- $22.09M
- Expected Revenue
- $23.84M
- Beat/Miss
- Missed by -$1.74M
- YoY Revenue Growth
- +9.89%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 02/21/2024
- Time
- After Close
- Conference Call
- Wednesday, February 21, 2024
CLVLF Upcoming Earnings
Clinuvel Pharmaceuticals 's next earnings date is estimated for February 23, 2027, based on past reporting schedules.
Q2 2024 Earnings Call Audio
CLVLF Q2 2024 Earnings Call
0:00 / 0:00
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
CLVLF Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 23, 2027 | 2027 (Q2) | 0.17- | 0.14 | ― | ― |
| Aug 27, 2026 | 2026 (Q4) | 0.340.32 | 0.3 | 7.06% (+0.02) | |
| Feb 25, 2026 | 2026 (Q2) | 0.200.14 | 0.19 | -26.43% (-0.05) | |
| Aug 27, 2025 | 2025 (Q4) | 0.190.30 | 0.34 | -11.13% (-0.04) | |
| Feb 26, 2025 | 2025 (Q2) | 0.150.19 | 0.15 | 32.08% (+0.05) | |
| Aug 29, 2024 | 2024 (Q4) | 0.300.34 | 0.26 | 30.34% (+0.08) | |
| Feb 21, 2024 | 2024 (Q2) | 0.180.15 | 0.15 | -3.64% (-0.01) | |
| Aug 29, 2023 | 2023 (Q4) | 0.250.26 | 0.21 | 24.67% (+0.05) | |
| Feb 22, 2023 | 2023 (Q2) | 0.210.15 | 0.08 | 92.98% (+0.07) | |
| Aug 30, 2022 | 2022 (Q4) | 0.300.21 | 0.24 | -14.85% (-0.04) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

